BioCentury
ARTICLE | Clinical News

AB-SA01: Phase I data

September 26, 2016 7:00 AM UTC

Top-line data from a double-blind, placebo-controlled, U.S. Phase I trial in 12 healthy volunteers ages 18-60 showed that once-daily 1x10 8 and 1x10 9 plaque-forming units (PFUs)/mL of topical AB-SA01...